IntelGenx technology platforms have been designed to address the commonly encountered challenges in oral drug delivery systems, such as first-pass metabolism, gastro-intestinal side effects, and slow or limited drug absorption of the drug in the GI tract.


Rapidly disintegrating thin polymeric film, improves drug performance and eases administration without the need for water. VersaFilmTM products have the potential to enhance bioavailability, accelerate onset of action, reduce side effects and ease administration primarily for pediatric, geriatric and dysphagic patients, thereby improving patient’ compliance and satisfaction.

RizaportTM VersaFilmTM is the first rizatriptan oral disintegrating film for the treatment of migrane to achieve EU marketing approval.

Intelgenx Facilities Photos